CRME

Cardiome Reports Fourth Quarter And Full Year 2012 Financial Results

[at noodls] – Cardiome to conduct conference call and webcast today, March 15, at 8:15 a.m. Eastern (5:15 a.m. Pacific) Vancouver, Canada, March 15, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click […]

Cardiome To Hold Fourth Quarter And Full Year 2012 Financial Results Conference Call On March 15

[at noodls] – + Click here for Webcast Vancouver, Canada, March 12, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the fourth quarter and fiscal year … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, […]

Cardiome Announces Settlement of Debt and Termination of LIine of Credit with Merck

[at noodls] – Vancouver, Canada, March 4, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced it has made the final payment to Merck, known as MSD outside the United States and Canada, of $13 million … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is […]

Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BrinavessTM (Vernakalant Intravenous)

[at noodls] – Vancouver, Canada, February 4, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the selection of Quintiles to provide comprehensive post-marketing lifecycle safety and global regulatory … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here to view […]

Cardiome Reaches Agreement With Merck To Retire Debt And Close Line Of Credit

[at noodls] – Vancouver, Canada, December 11, 2012 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the company has reached an agreement with Merck to settle its debt obligations stemming from … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here […]

Cardiome Reports Third Quarter Results

[at noodls] – Vancouver, Canada, November 13, 2012 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the third quarter ended September 30, 2012. Amounts, unless specified otherwise, … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboard […]

NASDAQ Approves Cardiome’s Request to Transfer its Listing to the NASDAQ Capital Market

[at noodls] – VANCOUVER, Canada, – October 25, 2012 – Cardiome Pharma Corp. (TSX: COM, Nasdaq: CRME) announced today that the NASDAQ Listing Qualifications Staff has approved the Company’s request to transfer its listing … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboard […]

Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome

[at noodls] – VANCOUVER, CANADA and WHITEHOUSE STATION, N.J., SEPTEMBER 26, 2012 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboard […]